CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
-7.39%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$821M
AUM Growth
+$821M
(-51%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-127.24%
Top 10 Holdings %
Top 10 Hldgs %
68.05%
Holding
41
New
9
Increased
2
Reduced
15
Closed
14
Top Buys
| 1 |
Protagonist Therapeutics
PTGX
|
$46.3M |
| 2 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
$30.7M |
| 3 |
Heron Therapeutics
HRTX
|
$29.7M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$28.7M |
| 5 |
MTEM
Molecular Templates, Inc.
MTEM
|
$19M |
Top Sells
| 1 |
Actinium Pharmaceuticals
ATNM
|
$351M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$123M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$98.2M |
| 4 |
Akebia Therapeutics
AKBA
|
$95.5M |
| 5 |
CareDx
CDNA
|
$79.1M |
Sector Composition
| 1 | Healthcare | 84.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
MacroGenics
MGNX
$110M
| $94.4M | 11.5% |
3,747,298
-294,237
| -7% | -$7.41M |
|
|
GNMK
2
DELISTED
GenMark Diagnostics, Inc
GNMK
| $75.3M | 9.17% |
5,299,863
-1,594,618
| -23% | -$22.6M |
|
3
Mersana Therapeutics
MRSN
$35M
| $64.6M | 7.87% |
3,468,171
-2,428,155
| -41% | -$45.2M |
|
4
Atara Biotherapeutics
ATRA
$86.7M
| $60.7M | 7.4% |
4,685,527
-552,691
| -11% | -$7.16M |
|
|
KDMN
5
DELISTED
Kadmon Holdings, Inc.
KDMN
| $54.9M | 6.69% |
14,007,548
-1,703,000
| -11% | -$6.68M |
|
|
APTO
6
DELISTED
Aptose Biosciences, Inc.
APTO
| $48M | 5.84% |
7,994,904
+1,025,000
| +15% | +$6.15M |
|
|
7
Protagonist Therapeutics
PTGX
$3.66B
| $46.3M | 5.64% |
+2,369,709
| New | +$46.3M |
|
8
Compugen
CGEN
$134M
| $42.9M | 5.22% |
2,637,421
-1,440,000
| -35% | -$23.4M |
|
9
Kiniksa Pharmaceuticals
KNSA
$2.54B
| $36.4M | 4.43% |
2,374,392
-468,992
| -16% | -$7.19M |
|
10
Aprea Therapeutics
APRE
$9.15M
| $35.1M | 4.28% |
1,459,411
+207,226
| +17% | +$4.99M |
|
|
LMNL
11
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
| $34.3M | 4.18% |
3,084,627
-202,684
| -6% | -$2.26M |
|
12
Assembly Biosciences
ASMB
$185M
| $32.4M | 3.95% |
1,969,875
-1,205,660
| -38% | -$19.8M |
|
|
TCRR
13
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $30.7M | 3.74% |
+1,509,819
| New | +$30.7M |
|
|
14
Heron Therapeutics
HRTX
$202M
| $29.7M | 3.62% |
+2,005,218
| New | +$29.7M |
|
|
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
| $28.7M | 3.5% |
+602,732
| New | +$28.7M |
|
|
ISEE
16
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $21.7M | 2.64% |
3,844,994
-805,571
| -17% | -$4.54M |
|
|
MTEM
17
DELISTED
Molecular Templates, Inc.
MTEM
| $19M | 2.31% |
+1,736,012
| New | +$19M |
|
|
SIOX
18
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $15M | 1.82% |
3,236,335
-416,968
| -11% | -$1.93M |
|
19
Stereotaxis
STXS
$246M
| $11.2M | 1.37% |
3,135,176
-523,361
| -14% | -$1.87M |
|
20
CASI Pharmaceuticals
CASI
$35.6M
| $10M | 1.22% |
+6,560,000
| New | +$10M |
|
|
21
Actinium Pharmaceuticals
ATNM
$54M
| $7.69M | 0.94% |
793,170
-36,206,830
| -98% | -$351M |
|
22
Soleno Therapeutics
SLNO
$3.57B
| $7.63M | 0.93% |
3,040,000
| – | – |
|
23
Omeros
OMER
$292M
| $4.89M | 0.6% |
484,042
-3,685,830
| -88% | -$37.2M |
|
24
ADMA Biologics
ADMA
$4.1B
| $3.72M | 0.45% |
1,558,290
-1,100,000
| -41% | -$2.63M |
|
|
DFHTU
25
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
| $2.66M | 0.32% |
+250,000
| New | +$2.66M |
|